A consensus statement emphasizes the underdiagnosis and undertreatment of cardiovascular disease in women, highlighting the need for targeted interventions. The statement recommends the establishment of women's heart champions and hubs to improve diagnosis and treatment outcomes.
A new study found an association between breast arterial calcifications and cardiovascular disease in women, suggesting mammograms could be a warning sign. Women with breast arterial calcifications were more likely to experience atherosclerotic heart disease, with a 23% increased risk compared to those without.
Scientists at deCODE genetics have discovered rare sequence variants in ITSN1 linked to Parkinson's Disease. These variants may contribute to disease pathogenesis through CDC42 dysregulation and dopaminergic neuron degeneration.
A new model developed by Penn State researchers more accurately predicts the causal relationship between genetic and environmental factors in disease development. The study found that lifestyle and environmental factors play a larger role than previously believed, offering new opportunities to mitigate disease risk.
Early Lyme disease can be difficult to diagnose due to its flu-like symptoms and the limitations of current testing methods. The new guidance article provides recommendations for clinicians to improve Lyme disease outcomes by assessing criteria for positivity and mitigating factors, as well as optimal timing of testing.
A new study by UCLA Health reveals racial disparities in Huntington's disease diagnoses, with Black patients receiving diagnoses one year later than White patients. The study analyzed nearly 5,000 patient data points and found that these disparities may exacerbate underrepresentation of minority groups in clinical trials.
A study published in Radiology found that brain connectivity on MRI scans can predict the progression of brain atrophy in patients with mild Parkinson's disease. The researchers used MRI data to generate a map of the brain's neural connections, which showed potential in predicting gray matter atrophy accumulation over time.
A new study led by Chapman University researchers found that combining Donepezil and Memantine significantly increased the probability of five-year survival for Alzheimer's disease patients. The combined use of these two medications reduced mortality rates by 0.05, or 6.4%, compared to no treatment and single-drug use.
A new NIH study using human cerebral organoids suggests a substantial species barrier preventing the transmission of chronic wasting disease from cervids to people. Researchers found no infection in healthy human cerebral organoids exposed to CWD prions for up to six months.
A study analyzed gene patterns of over 1,000 Lyme disease patients and identified a special gene variant associated with the disease. This genetic predisposition leads to reduced anti-inflammatory processes, fewer antibodies against Borrelia, and increased disease duration.
The study, conducted by Children's Hospital Colorado, found improvements in symptoms and quality of life for children diagnosed with celiac disease after participating in a mass screening program. Mass screening for pediatric celiac disease may become more common in the US, following similar conclusions drawn from European studies.
A new study found that genetic variants in lysosomal genes may contribute to the development of Parkinson's disease in individuals exposed to high levels of pesticides. The research suggests a potential gene-environment interaction, where minor changes in these genes can lead to increased disease risk under stress.
A global consortium has studied the connection between a specific gene variation and Pick's disease, a rare form of early-onset dementia. The research found that the MAPT H2 genetic variant is associated with an increased risk of Pick's disease in people of European descent.
Global disease burden rates dropped by 14.2% between 2010 and 2019, but the COVID-19 pandemic interrupted this trend, causing a 4.1% increase in disease burden in 2020 and a 7.2% increase in 2021.
A new hypothesis paper proposes that Parkinson's disease starts in either the brain's smell center or the body's intestinal tract, tied to environmental factors. The study suggests that exposure to pesticides, air pollution, and tainted food may predispose to the disease.
A new study found similarities in protein structures of Aβ and tau filaments between individuals with Alzheimer's disease and those with both conditions. This knowledge is crucial for understanding Alzheimer's disease in people with Down syndrome and assessing clinical trial inclusion.
Researchers successfully transmitted familial Alzheimer's disease to normal lab mice through bone marrow stem cell transplant. The recipients developed cognitive decline and amyloid buildup at an accelerated rate, highlighting the systemic nature of Alzheimer's disease.
Researchers discovered Lewy body disease changes in 9% of people over 50 without a clinical diagnosis, suggesting the disease may be more common than thought. Further studies are needed to confirm the results, but early detection is crucial for effective therapies.
Researchers have identified PDE4B as a potential target for treating Alzheimer's disease, where reducing its activity shows promise in improving memory and glucose metabolism. The study suggests that this approach may also protect against other forms of dementia, such as Huntington's disease.
Researchers found that patients with lung disease have a higher risk of developing heart disease, regardless of age or smoking status. The study, published in Orphanet Journal of Rare Diseases, suggests that Proteinase 3 enzyme may play a key role in this increased risk.
A team of researchers from Aarhus University has developed a simple measurement of protein in the urine that can predict which individuals are at high risk of rapid progression of chronic kidney disease. The study found that patients with newly diagnosed mild to moderate chronic kidney disease within three years have a 15% risk of rapi...
Researchers mapped potato blight outbreaks in the US from 1843-1845, revealing the disease's early spread and public understanding of its causes during the mid-19th century. The study provides insight into the disease's history and its impact on crop losses.
A recent survey found that 51% of Americans are unaware that heart disease is the leading cause of death in the US. This lack of knowledge can be deadly, with nearly half of adults having some form of cardiovascular disease.
Researchers discovered a previously unreported neuron type with vulnerability in Parkinson's disease, shedding light on the complexity of the disease and potential therapeutic targets. The study identified distinct transcriptomic signatures of this neuron type and found reduced RIT2 expression in Parkinson's disease patients.
A study from Monash University reveals the levels of NOX4 protein change as fatty liver disease progresses, offering hope for prevention and treatment. Removing NOX4 in obese mice leads to NASH and liver damage, while artificially raising its levels protects against it.
Researchers have developed new tools to assess disease progression of Alzheimer's disease in animal models, providing a translational approach for studying the disease. The tools use neuroimaging and network modeling techniques to analyze metabolic changes in the brain, confirming previous clinical findings.
Research found a significant linear relationship between age of coronary heart disease onset and dementia, highlighting the detrimental influence of premature cardiovascular events on brain health. Adults diagnosed with coronary heart disease at a young age may be at increased risk of developing dementia, Alzheimer's disease, and vascu...
Researchers at the University of Birmingham found that individuals with fatty liver disease are three times more likely to have a personality disorder than those without. Lifestyle modifications, such as changes in diet and exercise, can prevent disease progression but often fail to be implemented due to mental health factors.
A genome-wide study has identified 10 genomic regions associated with disease resistance in staghorn corals, a critically endangered species. The findings provide potential tools for improving disease resistance in the wild and nursery stocks, aiding conservation efforts.
A new set of diagnostic criteria for MAFLD has been developed, providing accurate and reliable diagnoses. This development has increased awareness of the disease and paved the way for further research and clinical trials, offering a significant step forward in diagnosing and treating MAFLD.
A new study found that having a previous disease increases an individual's risk of developing another disease, regardless of age and established risk factors. The study analyzed data from the UK Biobank cohort and found roughly double the expected rate of new diseases in certain groups, such as high-BMI men who smoke.
Researchers found that infected individuals with multiple strains of the T. cruzi parasite were better able to control the disease, while those with a progressive form had fewer strains. This discovery provides a new framework for developing more effective treatments and vaccines.
Research suggests that certain gut problems, such as gastroparesis, dysphagia, and irritable bowel syndrome (IBS), may precede the development of Parkinson's disease. A nationwide medical record network study found a significant association between these conditions and an increased risk of Parkinson's diagnosis.
A new special issue of the Journal of Huntington’s Disease highlights the critical impact of sleep dysfunction on HD patients. Disrupted sleep can alter metabolism, increase vulnerability to infection, and exacerbate disease outcomes.
The National Institute of Allergy and Infectious Diseases has awarded five projects to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which affects 10-20% of Lyme disease patients. The research will explore possible causes of persistent symptoms, including a misguided immune response and ongoing infection.
Researchers at Lund University have developed a spinal fluid test to detect Lewy body disease before symptoms emerge. The study found that nearly ten percent of individuals without initial cognitive or motor difficulties had Lewy bodies in their brains, highlighting the potential for early detection and treatment.
Researchers developed a computational technique combining genomic and tau PET imaging data to identify four subtypes of Alzheimer's disease. The integrated approach also revealed top genes associated with each subtype. This personalized diagnostic technique has potential for broad utility across various diseases.
A new study reveals sickle cell disease is far deadlier than its textbook description, with a total mortality burden of 373,000 deaths in 2021. The condition disproportionately affects children, adolescents, and young adults worldwide, highlighting the need for universal newborn screening and early intervention.
Chronic exposure to low levels of contaminant metals through household items, air, water, soil, and food increases the risk of cardiovascular disease. Monitoring environmental metal levels and testing for exposure are key steps to implement public health initiatives.
Research highlights chronic exposure to contaminant metals as a modifiable risk factor for cardiovascular disease. Monitoring environmental metal levels and testing individuals can help implement public health initiatives.
A University of Ottawa team has discovered a vital role for the VGLUT3 transporter protein in modulating the development of Huntington's disease. The study shows that blocking glutamate release through this protein can lead to an amelioration of the disease progression, offering new hope for potential treatment approaches.
A recent study published in The Lancet Neurology found that valbenazine significantly reduces chorea symptoms in patients with Huntington’s disease. The Phase III trial showed improvement as early as the second week of treatment, with consistently greater benefits compared to a placebo.
A study presented at Digestive Disease Week found that nearly 40% of TikTok posts about liver disease contain false or misleading information. Inaccurate claims often push fad diets, detox drinks, and herbal remedies as cures, with little engagement compared to accurate posts.
A study by University of Helsinki researchers identifies specific Desulfovibrio bacterial strains as a primary cause of Parkinson's disease in most cases. The findings suggest that these bacteria can trigger aggregation of the alpha-synuclein protein, potentially leading to disease progression.
Rheumatologists are crucial in detecting neurologic Lyme disease due to its broad spectrum of symptoms and signs. Early treatment has a favorable prognosis, but delayed diagnosis can lead to severe symptoms.
According to a new joint study, most children diagnosed with Lyme disease (75%) fully recovered within six months of completing antibiotic treatment. However, 22% of children experienced persistent symptoms after treatment, including some classified as post-treatment Lyme disease (PTLD) syndrome.
Researchers at Cedars-Sinai Medical Center identified a genetic variant associated with increased risk of developing perianal Crohn's disease, a debilitating manifestation of Crohn's disease. The study highlights the importance of targeting the alternative complement pathway and Complement Factor B (CFB) in treating this condition.
Researchers have found that commercially available smartphones and smartwatches can capture key features of early, untreated Parkinson's disease. These technologies could provide more objective and continuous ways to measure the disease, bringing new treatments to market faster for patients in the early stages.
A new study from the University of Eastern Finland identified 12 cell types involved in CAD pathogenesis. The genetic risk factors for CAD take effect via smooth vascular muscle cells, which change their phenotype as the disease progresses.
Patients with inflammatory bowel disease (IBD) are at a higher risk of developing lymphoma, particularly those with Crohn's disease. The risk is driven by both the disease activity and treatment, including immunomodulating drugs.
A study by Tokyo Medical and Dental University reveals that chronic kidney disease promotes vascular calcification by altering signaling molecules in blood vessel walls. The researchers identified four microRNAs that target a key pathway driving calcification, providing potential biomarkers and therapeutic targets for both diseases.
Early CTE disease process is characterized by different molecular pathways and gene expression changes compared to late-stage disease. Researchers analyzed post-mortem brain tissue from athletes with CTE and found distinct differences in neuro-inflammatory processes and genetic markers.
Researchers at Massachusetts General Hospital developed an accurate method for detecting Alzheimer's disease using routinely collected clinical brain images. The AI model detected Alzheimer's disease risk with 90.2% accuracy across five datasets, regardless of age or scanner manufacturer.
Researchers created human organoid models of fatty liver disease to shed light on drug responses and disease biology. The models identified a common mechanism for effective drugs that block lipid generation from sugars, suggesting personalized medicine applications.
A study published in eLife has linked infection with the bacterium Fusobacterium nucleatum to an increased risk of cardiovascular disease. The researchers found that individuals with high genetic risk scores for coronary heart disease were at elevated risk for cardiovascular events.
A recent study published in BMC Medicine found that higher consumption of free sugars is associated with a higher risk of cardiovascular disease. The researchers analyzed data from 110,497 individuals and found that consuming more free sugar, particularly from sugary drinks and sweets, increases the risk of heart disease and stroke. In...
Scientists have discovered that wrinkles in the cellular nucleus may be involved in common metabolic diseases such as diabetes and fatty liver disease. The new findings suggest that targeting these wrinkles could lead to novel treatments for non-alcoholic fatty liver disease, which affects 40% of people over age 70.
Researchers at Bar-Ilan University have developed a new treatment for Alzheimer's disease that targets the earliest, pre-symptomatic signs of the disease. The treatment, using cyclic peptides, has shown promise in diagnosing and preventing progression of the disease by blocking the formation of toxic oligomers.
A study found that unintentional weight loss in people with Down syndrome coincides with brain changes associated with Alzheimer's disease, indicating it could be an early predictor. The researchers suggest that weight loss may be a useful tool for making an earlier diagnosis.
A study found that people with coeliac disease have a 27% increased risk of cardiovascular disease compared to those without the condition. Despite this, they tend to have lower BMI and blood pressure, which are traditional cardiovascular risk factors.